mortality/aging
• at 9 to 12 months
|
immune system
N |
• despite immune system defects, B cell activation occurs normally
|
• B cells are more prone to spontaneous apoptosis and exhibit increased apoptosis in response to anti-Fas or anti-IgM stimulation compared to similarly treated wild-type cells
|
• 2-fold in the spleen and 7-fold in the lymph nodes
|
• mild
|
• mild
|
• mild
|
• levels of anti-DNA IgG1 are increased compared to in wild-type mice
• at 7 to 9 months, anti-nuclear antibodies are increased compared to in wild-type mice
|
hematopoietic system
• B cells are more prone to spontaneous apoptosis and exhibit increased apoptosis in response to anti-Fas or anti-IgM stimulation compared to similarly treated wild-type cells
|
• Ter-119+ erythroid cells are increased 2-fold in the spleen compared to in wild-type mice
|
• 2-fold in the spleen and 7-fold in the lymph nodes
|
• mild
|
• mild
|
• mild
|
cellular
• B cells are more prone to spontaneous apoptosis and exhibit increased apoptosis in response to anti-Fas or anti-IgM stimulation compared to similarly treated wild-type cells
|
growth/size/body